Intensified adjunctive corticosteroid therapy for CNS tuberculomas

Area of Science:

• Neurology
• Infectious Diseases
• Immunology

Background:

• Central nervous system (CNS) tuberculomas are a severe form of extrapulmonary tuberculosis.
• Neurological complications and sequelae are common after treatment.
• Current tuberculosis guidelines lack specific recommendations for corticosteroid use in CNS tuberculomas versus tuberculous meningitis.

Observation:

• Five patients with CNS tuberculomas received intensified, prolonged dexamethasone treatment (up to 18 months).
• Initial treatment included standard four-drug anti-tuberculosis regimen plus adjuvant dexamethasone.
• Attempts to reduce or discontinue corticosteroids led to clinical deterioration, including seizures and new lesions.

Findings:

• Extended dexamethasone administration was necessary for clinical cure and resolution of CNS tuberculoma lesions.
• Unlike tuberculous meningitis, CNS tuberculomas may require significantly longer corticosteroid therapy.
• Gradual reduction or discontinuation of corticosteroids, as per current guidelines, can precipitate relapse.

Implications:

• Treatment protocols for CNS tuberculomas should be differentiated from those for tuberculous meningitis regarding corticosteroid duration.
• Further controlled clinical studies are warranted to validate the necessity of prolonged corticosteroid therapy for CNS tuberculomas.
• Optimized corticosteroid regimens may improve outcomes and reduce long-term neurological deficits in CNS tuberculoma patients.